🚧 Under construction — Data may be inaccurate. We are actively adding more companies and metrics.
AbbVie Inc. logo

AbbVie Inc.

$254.68+0.19
ABBV•Rank #24•Healthcare•Drug Manufacturers - General•52w: 184.63-261.64

Market Cap

$520.7B

Global Rank

#24

All-Time High

$521.5B

2026-11-14

Total Growth

+0%

since 2026

Market Cap Context

$61.2B revenue ¡ $20.1B operating income ¡ $4.2B net income

  • ●Operating margin: 32.8% on $61.2B in revenue.
  • ●R&D is 14.9% of revenue ($9.1B).
  • ●Net income margin: 6.9% — $4.2B in profit.
  • ●Free cash flow: $17.8B (29.1% of revenue).

Cost / Operating Expenses

Total operating expenses $41.1B

Total

$41.3B

Cost of revenue¡ Product / service delivery costs (COGS)$18.2B44.1%
Research & development$9.1B22.0%
Selling, general & administrative¡ Sales, marketing, and corporate overhead$14.0B33.9%

Capital Expenditures

$1.2B

This fiscal year (near-total AI infrastructure buildout)

Free Cash Flow

$17.8B

Trailing twelve months

Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.

Fundamentals (TTM)

Data: Financial Modeling Prep

P/E

124.9

EPS

$2.05

Net margin

5.8%

ROE

68.0%

Dividend yield

2.68%

Debt / Equity

2.65

About AbbVie Inc.

AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.

CEO: Robert A. MichaelHQ: North Chicago, USEmployees: 57,000www.abbvie.comWikipedia →

AbbVie Inc. Market Cap History (2026–2026)

AbbVie Inc. vs Sector Peers by Market Cap

Johnson & JohnsonJNJ
$680.2B
AbbVie Inc.ABBV
$520.7B
UnitedHealth Group IncorporatedUNH
$369.2B
Merck & Co., Inc.MRK
$356.1B
Novartis AGNOVN.SW
$287.2B
AstraZeneca PLCAZN
$285.4B
Thermo Fisher Scientific Inc.TMO
$256.1B
Amgen Inc.AMGN
$250.1B

Compare AbbVie Inc.

Ranking History

YearMarket CapRankYoY Change
2026$520.7B#24+31.1%
2025$397.2B#24(↑4)+33.1%
2024$298.5B#28(↑3)+18.9%
2023$251.1B#31(↓5)-0.2%
2022$251.7B#26(↑20)+24.0%
2021$203.0B#46+32.4%
2020$153.3B#46(↑7)+27.7%
2019$120.0B#53(↓17)+1.5%
2018$118.3B#36-1.0%
2017$119.4B#36(↑15)+60.1%
2016$74.6B#51(↑2)+9.8%
2015$67.9B#53(↓4)-6.5%
2014$72.7B#49(↑5)+27.9%
2013$56.8B#54

Other Healthcare Companies

FAQ

What is AbbVie Inc.'s market cap?

AbbVie Inc. (ABBV) has a market capitalization of $520.7B, making it the #24 largest company in the world by market cap.

What was AbbVie Inc.'s highest market cap?

AbbVie Inc.'s all-time high market cap was $521.5B, reached in 2026-11-14. Its highest rank was #24 in 2026.

What sector is AbbVie Inc. in?

AbbVie Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.

How has AbbVie Inc.'s market cap changed over time?

AbbVie Inc. has been tracked since 2026. Its market cap has grown by 0% from $520.7B in 2026 to $520.7B today.